TLX today
$9.36-$0.37 (-3.75%)close Nov 12, 2026Trend
DailyDowntrend (confirmed)
4 hourStrong Bearish
1 hourDescending Triangle
15 minStrong Bearish
5 minStrong Bearish
Daily trend turns up above $11.24
Key levels
Resistance$10.06
Resistance$9.60
Support$8.98
Support$8.45
Latest news & SEC filings
GuidanceTalanx posts strong Q3 results, lifts 2026 profit forecast
ProductHDI Seguros finishes moving Sompo life insurance portfolio to insureMO platform
AnalystAnalyst Keeps $22 Target and Outperform Rating on Telix Pharmaceuticals
All TLX news →About Telix Pharmaceuticals
Telix Pharmaceuticals is an Australian biopharmaceutical company focused on radiopharmaceuticals for cancer imaging and therapy. Its commercial products include Illuccix and Gozellix, used in prostate cancer imaging, sold in the United States and other markets. The company also develops a pipeline of diagnostic and therapeutic product candidates and operates in Australia, the United States, Europe and other regions.
Based on the company's 20-F filed Feb 20, 2026.
Nasdaq · Healthcare
Telix Pharmaceuticals Ltd (TLX)
What Is the Price Target for TLX?
SEPT Low Target
$17.00
SEPT Mid Target
$20.00
SEPT High Target
$23.00
Analyst Consensus
$20.00
Is TLX a Buy or Sell Right Now?
Thesis
- •Revenue growing 53.9% YoY with STRONG trend — consistent growth.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for TLX.
Start Free Trial →Is TLX Overvalued or Undervalued?
Valuation Verdict
OVERVALUED
Methods Used
P/E Forward, P/B, PEG, Analyst Consensus
Fair Value
$12.36
30
Moat Score
NONE
2/9
Piotroski Score
2.4
Altman Z-Score
What Is Smart Money Doing with TLX?
Insider Signal
NEUTRAL
2 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
LOW
Signal: NEUTRAL
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →TLX Growth Story
Revenue YoY
53.9%
3yr Revenue CAGR
96.0%
EPS Growth YoY
-122.57%
FCF Growth YoY
-388.4%
Revenue Trend
STRONG
Dark Pool Trades for TLX
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for TLX, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 11:31:13 | $9.60 | 2,000 | $$19K | BUY |
| 21:00:17 | $9.72 | 1,158 | $$11K | SELL |
| 17:33:57 | $9.76 | 19,791 | $$193K | BUY |
| 17:16:39 | $9.70 | 1,320 | $$13K | BUY |
| 16:47:22 | $9.69 | 4,697 | $$46K | BUY |
5 dark pool trades shown · $$282K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Telix Pharmaceuticals Ltd (TLX) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (2 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →TLX — frequently asked questions
What is TLX stock price today?
Telix Pharmaceuticals Ltd (TLX) is at $9.36, down 3.75% (-$0.37) at the Nov 12, 2026 close.
Why is TLX stock moving today?
Latest TLX news — Nov 12, 2026: Talanx posts strong Q3 results, lifts 2026 profit forecast · Nov 4, 2026: HDI Seguros finishes moving Sompo life insurance portfolio to insureMO platform
What is the TLX price target?
The average analyst price target for TLX is $20.00, ranging from $20 to $20, based on 2 analysts.
What do analysts rate TLX?
Analyst ratings for TLX: 0 Buy, 11 Hold, 0 Sell — consensus Hold.
Did TLX beat earnings?
TLX last reported on Aug 19, 2026: EPS $0.11 vs $0.04 expected — a beat of 140.3%.
Does TLX pay a dividend?
TLX does not currently pay a dividend.
How much debt does TLX have?
Telix Pharmaceuticals Ltd reported $784M of debt and $213M of cash (Dec 31, 2025).
What are TLX support and resistance levels?
Support: $8.98, $8.45, $7.76. Resistance: $9.60, $10.06, $10.43.
What are insiders doing with TLX?
Insider activity: NEUTRAL, 2 buys and 0 sells in the last 90 days.
What is the latest news on TLX?
Nov 12, 2026: Talanx posts strong Q3 results, lifts 2026 profit forecast · Nov 4, 2026: HDI Seguros finishes moving Sompo life insurance portfolio to insureMO platform · Oct 21, 2026: Analyst Keeps $22 Target and Outperform Rating on Telix Pharmaceuticals